Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men

Affiliations

¹ Harvard Radiation Oncology Program, Boston, Massachusetts.
² Department of Medicine, University of California, San Francisco.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁴ Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco.

Brandon A Mahal et al. JAMA. 2018.

. 2018 Dec 18;320(23):2479-2481.

doi: 10.1001/jama.2018.11716.

¹ Harvard Radiation Oncology Program, Boston, Massachusetts.
² Department of Medicine, University of California, San Francisco.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁴ Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco.

No abstract available

Comment in

Re: Prostate Cancer-specific Mortality Across Gleason Scores in Black vs Nonblack Men.
Wallis CJD, Klotz L, Klaassen Z. Wallis CJD, et al. Eur Urol. 2019 Jun;75(6):1036-1037. doi: 10.1016/j.eururo.2019.02.019. Epub 2019 Feb 26. Eur Urol. 2019. PMID: 30819526 No abstract available.
Racial Disparities in Low-Risk Prostate Cancer.
Ehdaie B, Carlsson S, Vickers A. Ehdaie B, et al. JAMA. 2019 May 7;321(17):1726-1727. doi: 10.1001/jama.2019.2060. JAMA. 2019. PMID: 31063566 No abstract available.